Mirzotamab clezutoclax
目录号 : KM37763 CAS No. : 2229859-12-3
Mirzotamab clezutoclax (ABBV-155) 是一种首创的抗体药物偶联物 (ADC),由三种成分组成:抗 B7-H3 单克隆抗体和 BCL2L1 (BCL-XL) 抑制剂 Clezutoclaxum 。Mirzotamab clezutoclax 可用于复发和/或难治性 (R/R) 实体瘤的研究。
规格 价格 是否有货 数量
1mg 询价 In-stock
5mg 询价 In-stock
10mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Mirzotamab clezutoclax (ABBV-155) is a first-in-class antibody-drug conjugate (ADC) with three components: an anti-B7-H3 monoclonal antibody, and BCL2L1 (BCL-XL) inhibitor Clezutoclaxum . Mirzotamab clezutoclax can be used for the study of relapsed and/or refractory (R/R) solid tumors.
CAS号
2229859-12-3
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2